CAU
MEDP icon

Caxton Associates (UK)’s Medpace MEDP Stock Holding History

Caxton Associates (UK)’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$340K Sell
708
-175
-20% -$89.6K 0.01% 578
2025
Q4 		$496K Sell
883
-19,921
-96% -$11.3M 0.01% 504
2025
Q3 		$10.7M Buy
+20,804
New +$9.08M 0.25% 37

Other funds holding MEDP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Caxton Associates (UK)'s MEDP Position: Q1 2026 in Review

Caxton Associates (UK) reduced its Medpace (MEDP) stake by 20% in Q1 2026, selling an estimated $89.6K and leaving 708 shares worth $340K. The position accounts for 0.01% of the portfolio, ranked #578.

Caxton Associates (UK) first reported a position in MEDP in Q3 2025 and has held it in 3 quarters since. The position peaked at $10.7M in Q3 2025. 729 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

  • Caxton Associates (UK) held 708 shares of Medpace worth $340K as of Q1 2026.
  • Caxton Associates (UK) sold 175 Medpace shares in Q1 2026, an estimated $89.6K.
  • Medpace made up 0.01% of Caxton Associates (UK)'s portfolio in Q1 2026, its #578 holding.
  • Caxton Associates (UK) first reported a position in Medpace in Q3 2025 and has held it in 3 quarters since.
  • Caxton Associates (UK)'s Medpace position peaked at $10.7M in Q3 2025.
  • 729 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on Caxton Associates (UK)'s 13F filing for Q1 2026, filed 14 May 2026.